CEL-SCI prices $5M public offering of 2.5M shares at $2.00/share

CEL SCI CORP

Gross proceeds of $5,000,000 from 2.5M shares at $2.00 per share; net proceeds ~$4.5M.
Offering expected to close July 20, 2023; ThinkEquity sole book-runner.
Net proceeds to fund continued development of Multikine and for general corporate purposes.
Shares offered pursuant to effective shelf registration statement S-3 (File No. 333-265995).

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

CEL SCI CORP entered into Underwriting Agreement with ThinkEquity, LLC as Representative of the several underwriters valued at approximately $4,500,000 (effective 2023-07-17).

Action: entry
Agreement: underwriting
Counterparty: ThinkEquity, LLC as Representative of the several underwriters
Value: approximately $4,500,000
Effective: 2023-07-17

Exact text from the filing

On July 17, 2023, CEL-SCI Corporation (the “Company”) entered into an Underwriting Agreement with ThinkEquity, LLC as Representative of the several underwriters, pursuant to which the Company agreed to issue and sell 2,500,000 shares of common stock at a public offering price of $2.00 per share. The Company expects to receive approximately $4,500,000 in net proceeds from the Offering, after deducting underwriting discounts and commissions and estimated offering expenses.

View on SEC.gov

801 material agreements filed in the last 30 days. Browse all material agreements →

CEL SCI CORP filing history →

Source: SEC EDGAR

accession 0001654954-23-009334

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.